The correlation between low-grade tumours and high c-Fos expression that we observed could also be demonstrated in a molecular comparison between serous ovarian carcinomas of varying grade and borderline (low malignant potential, LMP) tumours (Meinhold-Heerlein et al, 2005). The gene discussed is FOS; the disease is neoplasm.